Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Manipulating host resistance structure reveals impact of pathogen dispersal and environmental heterogeneity on epidemics.

Penczykowski RM, Parratt SR, Barrès B, Sallinen SK, Laine AL.

Ecology. 2018 Dec;99(12):2853-2863. doi: 10.1002/ecy.2526. Epub 2018 Nov 19.

PMID:
30289567
2.

Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis.

Gribouval O, Morinière V, Pawtowski A, Arrondel C, Sallinen SL, Saloranta C, Clericuzio C, Viot G, Tantau J, Blesson S, Cloarec S, Machet MC, Chitayat D, Thauvin C, Laurent N, Sampson JR, Bernstein JA, Clemenson A, Prieur F, Daniel L, Levy-Mozziconacci A, Lachlan K, Alessandri JL, Cartault F, Rivière JP, Picard N, Baumann C, Delezoide AL, Belar Ortega M, Chassaing N, Labrune P, Yu S, Firth H, Wellesley D, Bitzan M, Alfares A, Braverman N, Krogh L, Tolmie J, Gaspar H, Doray B, Majore S, Bonneau D, Triau S, Loirat C, David A, Bartholdi D, Peleg A, Brackman D, Stone R, DeBerardinis R, Corvol P, Michaud A, Antignac C, Gubler MC.

Hum Mutat. 2012 Feb;33(2):316-26. doi: 10.1002/humu.21661. Epub 2011 Dec 22. Review.

PMID:
22095942
3.

Genetic spectrum of hereditary neuropathies with onset in the first year of life.

Baets J, Deconinck T, De Vriendt E, Zimoń M, Yperzeele L, Van Hoorenbeeck K, Peeters K, Spiegel R, Parman Y, Ceulemans B, Van Bogaert P, Pou-Serradell A, Bernert G, Dinopoulos A, Auer-Grumbach M, Sallinen SL, Fabrizi GM, Pauly F, Van den Bergh P, Bilir B, Battaloglu E, Madrid RE, Kabzińska D, Kochanski A, Topaloglu H, Miller G, Jordanova A, Timmerman V, De Jonghe P.

Brain. 2011 Sep;134(Pt 9):2664-76. doi: 10.1093/brain/awr184. Epub 2011 Aug 11.

4.

Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.

Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL.

Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.

5.

No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome.

Vahteristo P, Koski TA, Näätsaari L, Kiuru M, Karhu A, Herva R, Sallinen SL, Vierimaa O, Björck E, Richard S, Gardie B, Bessis D, Van Glabeke E, Blanco I, Houlston R, Senter L, Hietala M, Aittomäki K, Aaltonen LA, Launonen V, Lehtonen R.

Fam Cancer. 2010 Jun;9(2):245-51. doi: 10.1007/s10689-009-9312-2.

PMID:
20091131
6.

Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.

Crawford JR, Santi MR, Cornelison R, Sallinen SL, Haapasalo H, MacDonald TJ.

J Neurooncol. 2009 Oct;95(1):49-60. doi: 10.1007/s11060-009-9908-2. Epub 2009 May 8.

PMID:
19424665
7.

Large genomic rearrangements and germline epimutations in Lynch syndrome.

Gylling A, Ridanpää M, Vierimaa O, Aittomäki K, Avela K, Kääriäinen H, Laivuori H, Pöyhönen M, Sallinen SL, Wallgren-Pettersson C, Järvinen HJ, Mecklin JP, Peltomäki P.

Int J Cancer. 2009 May 15;124(10):2333-40. doi: 10.1002/ijc.24230.

8.

Delays in the diagnosis and treatment of lung cancer.

Salomaa ER, Sällinen S, Hiekkanen H, Liippo K.

Chest. 2005 Oct;128(4):2282-8.

PMID:
16236885
9.

CHEK2 mutations in primary glioblastomas.

Sallinen SL, Ikonen T, Haapasalo H, Schleutker J.

J Neurooncol. 2005 Aug;74(1):93-5. No abstract available.

PMID:
16078115
10.

Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene.

Taillandier A, Sallinen SL, Brun-Heath I, De Mazancourt P, Serre JL, Mornet E.

J Clin Endocrinol Metab. 2005 Apr;90(4):2436-9. Epub 2005 Jan 25.

PMID:
15671102
11.

Absence of KLF6 gene mutations in human astrocytic tumors and cell lines.

Koivisto PA, Zhang X, Sallinen SL, Sallinen P, Helin HJ, Dong JT, Van Meir EG, Haapasalo H, Hyytinen ER.

Int J Cancer. 2004 Sep 10;111(4):642-3. No abstract available.

12.

Arm-specific multicolor fluorescence in situ hybridization reveals widespread chromosomal instability in glioma cell lines.

Sallinen SL, Sallinen P, Ahlstedt-Soini M, Haapasalo H, Helin H, Isola J, Karhu R.

Cancer Genet Cytogenet. 2003 Jul 1;144(1):52-60.

PMID:
12810256
13.

Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).

Antinheimo J, Sallinen SL, Sallinen P, Haapasalo H, Helin H, Horelli-Kuitunen N, Wessman M, Sainio M, Jääskeläinen J, Carpén O.

Acta Neurochir (Wien). 2000;142(10):1099-104; discussion 1104-5.

PMID:
11129530
14.

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helén PT, Schraml P, Kallioniemi OP, Kononen J.

Cancer Res. 2000 Dec 1;60(23):6617-22.

15.

Chromosome imbalances in familial gliomas detected by comparative genomic hybridization.

Paunu N, Sallinen SL, Karhu R, Miettinen H, Sallinen P, Kononen J, Laippala P, Simola KO, Helén P, Haapasalo H.

Genes Chromosomes Cancer. 2000 Dec;29(4):339-46. Review.

PMID:
11066078
16.

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

Sallinen PK, Sallinen SL, Helén PT, Rantala IS, Rautiainen E, Helin HJ, Kalimo H, Haapasalo HK.

Neuropathol Appl Neurobiol. 2000 Aug;26(4):319-31.

PMID:
10931365
17.

Cyclic expression of mRNA transcripts for connective tissue components in the mouse ovary.

Oksjoki S, Sallinen S, Vuorio E, Anttila L.

Mol Hum Reprod. 1999 Sep;5(9):803-8.

PMID:
10460217
18.

Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis.

Sallinen SL, Sallinen PK, Kononen JT, Syrjäkoski KM, Nupponen NN, Rantala IS, Helén PT, Helin HJ, Haapasalo HK.

J Pathol. 1999 Jul;188(3):289-93.

PMID:
10419598
19.

Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.

Haapasalo H, Sallinen S, Sallinen P, Helén P, Jääskeläinen J, Salmi TT, Paetau A, Paljärvi L, Visakorpi T, Kalimo H.

Neuropathol Appl Neurobiol. 1999 Apr;25(2):134-42.

PMID:
10216001
20.

Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.

Sallinen SL, Sallinen P, Haapasalo H, Kononen J, Karhu R, Helén P, Isola J.

Am J Pathol. 1997 Dec;151(6):1799-807.

21.

Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.

Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H, Kononen J.

Am J Pathol. 1997 Apr;150(4):1159-64.

22.

A real-time microprocessor QRS detector system with a 1-ms timing accuracy for the measurement of ambulatory HRV.

Ruha A, Sallinen S, Nissilä S.

IEEE Trans Biomed Eng. 1997 Mar;44(3):159-67.

PMID:
9216129

Supplemental Content

Loading ...
Support Center